AAAAAA

   
Results: 1-7 |
Results: 7
ERYTHROCYTIC PROTEIN-KINASE-C ACTIVITY IN PRIMARY HYPERTENSION
Authors: EK P TOOMIK R ERIKSSON S FRITHZ G RONQUIST G ENGSTROM L
Citation: P. Ek et al., ERYTHROCYTIC PROTEIN-KINASE-C ACTIVITY IN PRIMARY HYPERTENSION, Journal of internal medicine, 243(4), 1998, pp. 299-305
VALIDITY OF STUDIES ON DISTRIBUTION AND TRANSBILAYER MOVEMENT OF ERYTHROCYTE-MEMBRANE CHOLESTEROL - REPLY
Authors: FRITHZ G
Citation: G. Frithz, VALIDITY OF STUDIES ON DISTRIBUTION AND TRANSBILAYER MOVEMENT OF ERYTHROCYTE-MEMBRANE CHOLESTEROL - REPLY, Journal of hypertension, 14(11), 1996, pp. 1380-1380
DISTURBED ENERGY-BALANCE IN SKELETAL-MUSCLE OF PATIENTS WITH UNTREATED PRIMARY HYPERTENSION
Authors: RONQUIST G SOUSSI B FRITHZ G SCHERSTEN T WALDENSTROM A
Citation: G. Ronquist et al., DISTURBED ENERGY-BALANCE IN SKELETAL-MUSCLE OF PATIENTS WITH UNTREATED PRIMARY HYPERTENSION, Journal of internal medicine, 238(2), 1995, pp. 167-174
TRANS-BILAYER MOVEMENT OF ERYTHROCYTE-MEMBRANE CHOLESTEROL IN HUMAN ESSENTIAL-HYPERTENSION
Authors: FRITHZ G
Citation: G. Frithz, TRANS-BILAYER MOVEMENT OF ERYTHROCYTE-MEMBRANE CHOLESTEROL IN HUMAN ESSENTIAL-HYPERTENSION, Journal of hypertension, 13(12), 1995, pp. 1480-1481
DIRECT EFFECT OF INSULIN ON CA-45 UPTAKE IN HUMAN ERYTHROCYTES
Authors: PETTERSSON L FRITHZ G RONQUIST G
Citation: L. Pettersson et al., DIRECT EFFECT OF INSULIN ON CA-45 UPTAKE IN HUMAN ERYTHROCYTES, Journal of internal medicine, 236(2), 1994, pp. 197-201
TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN RESULTS IN DECREASED RED-CELL UPTAKE OF CA-45
Authors: LINDE T RONQUIST G SANDHAGEN B WIKSTROM B FRITHZ G PETTERSSON L DANIELSON BG
Citation: T. Linde et al., TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN RESULTS IN DECREASED RED-CELL UPTAKE OF CA-45, Nephron, 68(4), 1994, pp. 419-426
EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS
Authors: BEHOUNEK BD MARKOWITZ JS BERGMAN M MCGOVERN ME KASSLERTAUB KB VANHANEN H ELORANTA M JUVONEN J KANTOLA I KEKKI S KIVELA H KNUTAR F NISSEN M SALMI J SALONEN R TARPILA S TUNTURIHIHNALA H AMANN FW BERENDES G BONNER G DUBACH UC EGGSTEIN M FRANKENBERG HV FROER KL HOHL H HOPPE F KUMMER H MARZ W MOCCETTI T NOSEDA G REUTTER FW SCHWENKE R VOSSCHULTE G WAMBACH G WEIDMANN P BONNIER JJRM DEWEERD P HUIGE MC JANSEN LJ TERIJDT AJ TEVELDE K OLSSON AG LARSSON H ASPLUND J DAHLQVIST A LONNQVIST F FRITHZ G HOGLUND C KJELLSTROM T KUYLENSTIERNA J MOLLER B OSTERGREN J CRAMB R DAVIES J",IVERSON,"JOHNSTON GD MUNRO A PEACOCK I RITCHIE LD RITTER J RYLANCE PB SEVER PS SIMMONS RL
Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037
Risultati: 1-7 |